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A combination of three HPLC procedures applied to the venom of Gila monster (Heloderma suspecturn) 
has led to the purification to homogeneity of two bioactive components: (i)a 17.5 kDa protein, isolated 
on the basis of its potent secretory effect on dispersed rat pancreatic acini, was accordingly designated PSF 
(pancreatic secretory factor); (ii) a 5.9-kDa peptide, designated helodermin, was purified on the basis of 
its ability to stimulate adenylate cyclase in rat pancreatic membranes. PSF was unable to activate adenylate 
cyclase and, conversely, helodermin was devoid of secretory action. 
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1. INTRODUCTION 
In 1982, it was observed [l] that the venom from 
Gila monster exerts a potent secretory effect on 
dispersed pancreatic acini from guinea pig. 
Moreover, the venom causes a 50-fold increase in 
cyclic AMP and inhibits dose-dependently and 
competitively the binding of rZ51-vasoactive in- 
testinal peptide (VIP). The authors concluded that 
the venom contains a factor that interacts with VIP 
receptors and activates adenylate cyclase, thereby 
stimulating enzyme secretion from pancreatic 
acinar cells. 
tively, the activation of adenylate cyclase in pan- 
creatic plasma membranes and the stimulation of 
amylase secretion from dispersed acini. Indeed, 
when submitting the venom to anion exchange 
chromatography, at pH 7.0, a component 
stimulating adenylate cyclase eluted nearly im- 
mediately from the column while another factor 
stimulating amylase secretion eluted at higher ionic 
strength. We then decided to purify these two 
bioactive components, in order to circumstantiate 
their biological activities and chemical structure. 
We discovered recently that this conclusion did 
not hold true for the rat pancreas as two distinct 
components (at least) were responsible for, respec- 
This first report describes the purification pro- 
cedure of helodermin (a potent activator of 
adenylate cyclase) and PSF (the major pancreatic 
secretory factor) from Gila monster venom, by a 
combination of anion exchange HPLC, gel 
permeation HPLC, and reverse-phase HPLC. 
* To whom correspondence should be addressed 
Abbreviations: VIP, vasoactive intestinal peptide; PSF, 
pancreatic secretory factor from Gila monster venom; 
SDS-PAGE, sodium dodecyl sulfate-polyacrylamide gel 
electrophoresis 
2. EXPERIMENTAL 
2.1. Purification procedures 
The content of one flask (100 mg) of Gila 
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monster venom (Heloderma suspecturn, lot 
42F-0747 from Sigma, St. Louis) was dissolved in 
2 ml water and the resultant turbid solution was 
centrifuged for 30 min at 100000 x g. The clear 
supernatant was desalted by chromatography on a 
Sephadex G-15 column (1.2 x 15 cm) in 20 mM 
Tris-acetate (pH 7.0). The active fraction emerged 
with the void volume and represented 95 mg pro- 
tein when assayed as in [2]. This fraction (4 ml) 
was diluted with 1-propanol (30% final concentra- 
tion) and the resulting precipitate was discarded by 
centrifugation. The supernatant, containing the 
whole biological activity and 80 mg protein, was 
chromatographed by anion exchange HPLC on a 
TSK-545 DEAE column as indicated in fig. 1. Frac- 
tions rich in PSF and helodermin were pooled 
separately and further purified by reverse-phase 
HPLC on a Lichrosorb RP8 column (as detailed in 
fig.2) and thereafter by gel permeation 
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Fig.1. Anion exchange HPLC of Gila monster venom 
(80 mg protein) on TSK-545 DEAE (7.5 x 150 mm) 
equilibrated with 40 mM Tris-acetate buffer (pH 7.0) in 
30% propanol and eluted at 0.5 ml/min with a linear 
gradient of ammonium acetate in the equilibrating 
buffer. Fractions of 0.5 ml were collected. Stimulations 
of adenylate cyclase activity (hatched columns) and 
amylase secretion (black columns) were measured on 
l-p1 aliquots of each fraction and expressed as % 
maximal activity. Helodermin (Hd) and PSF were 
collected as indicated. 
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Fig.2. Reverse-phase HPLC on Lichrosorb RP-8 (4 x 
250 mm) of PSF (A) and helodermin (B), collected after 
anion exchange HPLC (fig. 1). The column was eluted at 
0.4 ml/min (1 fraction/min) with a linear gradient of 
1-propanol in 0.4 M ammonium acetate (pH 7.0). The 
active material was assayed as mentioned in the legend 
of fig.1 and collected as indicated. 
chromatography on two connected columns of 
TSK-G2000 SW and TSK-G3000 SW (see fig.3). 
Electrophoretic analysis was performed on SDS- 
polyacrylamide slab gels (18 x 20 x 0.7 cm) using 
the discontinuous buffer in [3] and a lo-20% 
acrylamide linear gradient gel with an 
acrylamide-bisacrylamide ratio of 20 : 1. The gels 
were fixed with formaldehyde and stained with 
Coomassie brilliant blue R 250 as in [4]. Protein 
standards were from Pharmacia Fine Chemicals 
(Uppsala). Synthetic porcine VIP was obtained 
from UCB Bioproducts (Brussels). Basic trypsin 
inhibitor was a gift from Bayer Pharma (Brussels). 
Synthetic porcine secretin was a generous gift from 
Dr W. Kiinig (Hoechst Aktiengesellschaft, 
Frankfurt/Main). 
2.2. Assays for biological activities 
The chromatographic tubes to be tested were 
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Fig.3. Gel permeation HPLC on two connected columns 
of TSK-G2000 SW (7.5 x 600 mm) and TSK-G3000 SW 
(7.5 x 600 mm) of PSF (A) and helodermin (B), 
collected after reverse-phase HPLC (fig.2). The columns 
were eluted at 0.2 ml/min (1 fraction/2 min) with 30% 
I-propanol in 1 M ammonium acetate (pH 7.0). The 
active material was assayed as mentioned in the legend 
of fig.1 and collected as indicated, after checking the 
purity of each fraction by SDS-PAGE (see fig.4). The 
arrows indicate the elution position of soybean trypsin 
inhibitor (STI) and secretin. 
lyophilized to dryness and the dry residue dissolved 
with the initial volume of distilled water. The 
equivalent of 1~1 of each fraction was used, per 
assay, for the measurement of either adenyiate 
cyclase stimulation or amylase secretion. 
Rat pancreatic membranes were prepared as in 
[S] but 2-mercaptoethanol was omitted from all 
buffers used. Adenylate cyclase activity was 
measured as in [6]; i.e., in the presence of IOQM 
GTP and according to [‘?I. 
Rat pancreatic acini were prepared as in [8], and 
0.2-ml aliquots of dispersed acini were incubated 
per assay. The released amylase activity was deter- 
mined as in 191. 
The columns used were: TSK-545 DEAE, TSK- 
G2000 SW and TSKG3000 SW from LKB (Brom- 
ma) and Lichrosorb RP-8 from Merck 
(~armstadt). 
3. RESULTS AND DISCUSSION 
Fig.1 shows the initial anion exchange 
chromatography separating PSF from helodermin. 
Only the major peaks of biological activities were 
pooled for further purification and there was no 
overlapping between the fractions stimulating 
adenylate cyclase activity of pancreatic membranes 
and those stimulating amylase secretion from 
isolated acini. PSF was, therefore, a potent 
secretagogue unable to activate adenylate cyclase. 
On the contrary, helodermin was a potent ac- 
tivator of adenylate cyclase activity (like VIP and 
secretin) but inactive on amylase secretion (unlike 
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Fig.4. SDS-PAGE of chromatographically purified 
heiodermin (lane 4) and PSF (lane 6). Electrophoresis 
was performed on a lo-20% acrylamide gradient as 
described in section 2. M, standards were: phosphorylase 
6, 94000; bovine serum albumin, 67000; ovalbumin, 
43000; carbonic anhydrase, 30000; soybean trypsin 
inhibitor, 20100; and cr-lactalbumin, 14400 (lane 1); 
ovalbumin, soybean trypsin inhibitor, basic trypsin 
inhibitor, 6500 (lane 2); VIP, 3300 (lane 3); basic trypsin 
inhibitor (lane 5). 
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secretin, and even unlike VIP which is still a poor 
secretagogue on the rat pancreas). 
PSF and helodermin were further purified by 
reverse-phase HPLC (fig.2) and by gel permeation 
HPLC (fig.3). The purity of the fractions col- 
lected after gel permeation HPLC was checked by 
SDS-PAGE (see below) and the uncontaminated 
fractions, subsequently pooled as indicated in 
fig.3, yielded, respectively, 130 pg PSF and 380 ,ug 
helodermin when starting from 100 mg crude 
venom. The recovery of PSF could be improved by 
increasing the resolution power of both reverse- 
phase HPLC and gel permeation HPLC or by 
simply recycling the contaminated fractions. 
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